Form 4 for DGX Quest Diagnostics
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001022079-24-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | 2024-02-22 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.14 | -821 | 70.8K | -1% | -$103.6K | |
| 2024-02-23 | 2024-02-21 | DGX | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $125.02 | -493 | 71.6K | -0.7% | -$61.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | S | D | 821 | $126.14 | 70,800 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-21 | F | D | 493 | $125.02 | 71,621 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |